Clinical Trial Update: Treatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to Bones [Phase 2]

View source ↗

Summary

NCI-sponsored Phase 2 trial evaluating Sn-117m-DTPA bone-targeted radiation for cancer-related bone pain in men with prostate cancer that has spread to the bone…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Sn-117m-DTPA (Sn-117m-DTPA)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Castration-Resistant Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone | Phase 2 | Status: TERMINATED | Results posted: 2024-04-16